Dedicated to producing the highest quality of products and specialist facilities throughout the world, Sasol Wax’s extremely pure waxes, petroleum jellies and white mineral oils are available to the pharmaceutical industry any time, anywhere.
The Sasol Wax Group is a leading specialist for natural and synthetic paraffin waxes, petroleum jellies and pharmaceutical paraffin oil. Available worldwide, Sasol Wax products are used in a variety of markets and end products and are produced around the world at its specialist facilities in Germany, South Africa, Egypt and the US. The company’s headquarters in Hamburg, Germany, specialises in products made from mineral oil hydrocarbons. In Sasolburg, South Africa, Fischer-Tropsch waxes are produced by synthetic means.
The Sasol Wax sales teams are part of a global network that can advise and supply clients in any location. Alternatively, the company base in Hamburg covers the whole world and will provide advice on applications technology. Sasol Wax is committed to working with the client to seek new opportunities for its products.
Quality characteristics
Sasol Wax’s range includes hard paraffin wax (Ph.Eur/USPNF/ FDA), microcrystalline wax (DAC/USP-NF/FDA), petroleum jelly (petrolatum) white and yellow (Ph.Eur/USP/FDA), synthetic paraffin wax (USP/FDA) and pharmaceutical white oil/liquid paraffin (Ph.Eur/USP-NF/FDA). The firm’s solid, semi-solid and liquid paraffin products of pharmacopoeia quality are produced by high-pressure hydrogenation at high-quality standards in an environmentally friendly and safe way. Sasol Wax products are largely free of all impurities.
Constant product properties guarantee safe use. The quality characteristics of the company’s products are tested and recorded for each batch by an extensively equipped quality control laboratory. In collaboration with customers, Sasol Wax develops tailor-made products using quality control methods, which have made it possible to implement unique tests for many products, the results of which have been used successfully in applications.
In addition to customer-specific requirements, Sasol Wax defines its own standard specifications in such a way as to make them considerably more stringent than the broadly formulated pharmacopoeia limits, thus guaranteeing a higher level of safety in each application.
Sasol Wax is commtted to production in accordance with the basic GMP regulations and works to the Joint IPEC/ PQG Good Manufacturing Practices Guide for Pharmaceutical Excipients. It has achieved a standard that has received unconditional approval from the VFA, the German Association of Research-based Pharmaceutical Companies.
Future investment
Quality and security of supply is the main focus of Sasol Wax. As one of the largest producers worldwide, it operates a comprehensive management system for securing resources and sources of supply. Constant adaptations to technical progress also guarantees quality and supply capacity in the future.
Expansion of its capacities for Fischer-Tropsch waxes, which is already underway, is helping the company to increase its independence against a backdrop of diminishing crude oil reserves and will enable the continued use of paraffin waxes and petroleum jellies as indispensable inactive substances in the production of pharmaceuticals in the years to come.
To confirm its presence on the global stage, the company will present its pharmaceutical product portfolio at this year’s CPhI in Frankfurt, Germany, from 25 to 27 October.